APO Research
Talk to an analyst

APO RESEARCH · REPORT

Paromomycin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Paromomycin Market Analysis and Forecast 2026-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchParomomycin Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Paromomycin Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Paromomycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Paromomycin Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Paromomycin Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Paromomycin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Paromomycin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Paromomycin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Paromomycin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Paromomycin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Paromomycin include Shanhe Pharm, Kaifeng Pharm, Pfizer, Changrui Pharm and ERFA Canada, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Paromomycin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Paromomycin, also provides the sales of main regions and countries. Of the upcoming market potential for Paromomycin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Paromomycin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Paromomycin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Paromomycin sales, projected growth trends, production technology, application and end-user industry.

Paromomycin Segment by Company

Shanhe Pharm

Kaifeng Pharm

Pfizer

Changrui Pharm

ERFA Canada

Paromomycin Segment by Type

95% Purity Type

96% Purity Type

Others

Paromomycin Segment by Application

Paromomycin Sulfate

Paromomycin Injection

Paromomycin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Paromomycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Paromomycin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Paromomycin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Paromomycin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Paromomycin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Paromomycin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Paromomycin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 95% Purity Type Major Manufacturers Table 3. 96% Purity Type Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Paromomycin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Paromomycin Sulfate Major Manufacturers Table 7. Paromomycin Injection Major Manufacturers Table 8. Paromomycin Industry Trends Table 9. Paromomycin Industry Drivers Table 10. Paromomycin Industry Opportunities and Challenges Table 11. Paromomycin Industry Restraints Table 12. Global Paromomycin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Paromomycin Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Paromomycin Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Paromomycin Revenue Market Share by Region (2021-2026) Table 16. Global Paromomycin Revenue Market Share by Region (2027-2032) Table 17. Global Paromomycin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (tons) Table 18. Global Paromomycin Sales by Region (2021-2026) & (tons) Table 19. Global Paromomycin Sales by Region (2027-2032) & (tons) Table 20. Global Paromomycin Sales Market Share by Region (2021-2026) Table 21. Global Paromomycin Sales Market Share by Region (2027-2032) Table 22. Global Paromomycin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Paromomycin Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Paromomycin Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Paromomycin Sales Market Share by Manufacturers (2021-2026) Table 26. Global Paromomycin Sales Price (US$/ton) of Manufacturers (2021-2026) Table 27. Global Paromomycin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Paromomycin Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Paromomycin Manufacturers, Product Type & Application Table 30. Global Paromomycin Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Paromomycin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Paromomycin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Paromomycin Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Paromomycin Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Paromomycin Revenue Market Share by Type (2021-2026) Table 37. Global Paromomycin Revenue Market Share by Type (2027-2032) Table 38. Global Paromomycin Sales by Type 2021 VS 2025 VS 2032 (tons) Table 39. Global Paromomycin Sales by Type (2021-2026) & (tons) Table 40. Global Paromomycin Sales by Type (2027-2032) & (tons) Table 41. Global Paromomycin Sales Market Share by Type (2021-2026) Table 42. Global Paromomycin Sales Market Share by Type (2027-2032) Table 43. Global Paromomycin Price by Type (2021-2026) & (US$/ton) Table 44. Global Paromomycin Price by Type (2027-2032) & (US$/ton) Table 45. Global Paromomycin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Paromomycin Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Paromomycin Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Paromomycin Revenue Market Share by Application (2021-2026) Table 49. Global Paromomycin Revenue Market Share by Application (2027-2032) Table 50. Global Paromomycin Sales by Application 2021 VS 2025 VS 2032 (tons) Table 51. Global Paromomycin Sales by Application (2021-2026) & (tons) Table 52. Global Paromomycin Sales by Application (2027-2032) & (tons) Table 53. Global Paromomycin Sales Market Share by Application (2021-2026) Table 54. Global Paromomycin Sales Market Share by Application (2027-2032) Table 55. Global Paromomycin Price by Application (2021-2026) & (US$/ton) Table 56. Global Paromomycin Price by Application (2027-2032) & (US$/ton) Table 57. Shanhe Pharm Company Information Table 58. Shanhe Pharm Business Overview Table 59. Shanhe Pharm Paromomycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 60. Shanhe Pharm Paromomycin Product Portfolio Table 61. Shanhe Pharm Recent Development Table 62. Kaifeng Pharm Company Information Table 63. Kaifeng Pharm Business Overview Table 64. Kaifeng Pharm Paromomycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 65. Kaifeng Pharm Paromomycin Product Portfolio Table 66. Kaifeng Pharm Recent Development Table 67. Pfizer Company Information Table 68. Pfizer Business Overview Table 69. Pfizer Paromomycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 70. Pfizer Paromomycin Product Portfolio Table 71. Pfizer Recent Development Table 72. Changrui Pharm Company Information Table 73. Changrui Pharm Business Overview Table 74. Changrui Pharm Paromomycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 75. Changrui Pharm Paromomycin Product Portfolio Table 76. Changrui Pharm Recent Development Table 77. ERFA Canada Company Information Table 78. ERFA Canada Business Overview Table 79. ERFA Canada Paromomycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 80. ERFA Canada Paromomycin Product Portfolio Table 81. ERFA Canada Recent Development Table 82. North America Paromomycin Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Paromomycin Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Paromomycin Sales by Type (2021-2026) & (tons) Table 85. North America Paromomycin Sales by Type (2027-2032) & (tons) Table 86. North America Paromomycin Sales Price by Type (2021-2026) & (US$/ton) Table 87. North America Paromomycin Sales Price by Type (2027-2032) & (US$/ton) Table 88. North America Paromomycin Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Paromomycin Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Paromomycin Sales by Application (2021-2026) & (tons) Table 91. North America Paromomycin Sales by Application (2027-2032) & (tons) Table 92. North America Paromomycin Sales Price by Application (2021-2026) & (US$/ton) Table 93. North America Paromomycin Sales Price by Application (2027-2032) & (US$/ton) Table 94. North America Paromomycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Paromomycin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 96. North America Paromomycin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 97. North America Paromomycin Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 98. North America Paromomycin Sales by Country (2021-2026) & (tons) Table 99. North America Paromomycin Sales by Country (2027-2032) & (tons) Table 100. North America Paromomycin Sales Price by Country (2021-2026) & (US$/ton) Table 101. North America Paromomycin Sales Price by Country (2027-2032) & (US$/ton) Table 102. United States Paromomycin Revenue (2021-2032) & (US$ Million) Table 103. Canada Paromomycin Revenue (2021-2032) & (US$ Million) Table 104. Mexico Paromomycin Revenue (2021-2032) & (US$ Million) Table 105. Europe Paromomycin Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe Paromomycin Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe Paromomycin Sales by Type (2021-2026) & (tons) Table 108. Europe Paromomycin Sales by Type (2027-2032) & (tons) Table 109. Europe Paromomycin Sales Price by Type (2021-2026) & (US$/ton) Table 110. Europe Paromomycin Sales Price by Type (2027-2032) & (US$/ton) Table 111. Europe Paromomycin Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Paromomycin Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Paromomycin Sales by Application (2021-2026) & (tons) Table 114. Europe Paromomycin Sales by Application (2027-2032) & (tons) Table 115. Europe Paromomycin Sales Price by Application (2021-2026) & (US$/ton) Table 116. Europe Paromomycin Sales Price by Application (2027-2032) & (US$/ton) Table 117. Europe Paromomycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Paromomycin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. Europe Paromomycin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. Europe Paromomycin Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 121. Europe Paromomycin Sales by Country (2021-2026) & (tons) Table 122. Europe Paromomycin Sales by Country (2027-2032) & (tons) Table 123. Europe Paromomycin Sales Price by Country (2021-2026) & (US$/ton) Table 124. Europe Paromomycin Sales Price by Country (2027-2032) & (US$/ton) Table 125. Germany Paromomycin Revenue (2021-2032) & (US$ Million) Table 126. France Paromomycin Revenue (2021-2032) & (US$ Million) Table 127. U.K. Paromomycin Revenue (2021-2032) & (US$ Million) Table 128. Italy Paromomycin Revenue (2021-2032) & (US$ Million) Table 129. Russia Paromomycin Revenue (2021-2032) & (US$ Million) Table 130. Spain Paromomycin Revenue (2021-2032) & (US$ Million) Table 131. Netherlands Paromomycin Revenue (2021-2032) & (US$ Million) Table 132. Switzerland Paromomycin Revenue (2021-2032) & (US$ Million) Table 133. Sweden Paromomycin Revenue (2021-2032) & (US$ Million) Table 134. Poland Paromomycin Revenue (2021-2032) & (US$ Million) Table 135. China Paromomycin Revenue by Type (2021-2026) & (US$ Million) Table 136. China Paromomycin Revenue by Type (2027-2032) & (US$ Million) Table 137. China Paromomycin Sales by Type (2021-2026) & (tons) Table 138. China Paromomycin Sales by Type (2027-2032) & (tons) Table 139. China Paromomycin Sales Price by Type (2021-2026) & (US$/ton) Table 140. China Paromomycin Sales Price by Type (2027-2032) & (US$/ton) Table 141. China Paromomycin Revenue by Application (2021-2026) & (US$ Million) Table 142. China Paromomycin Revenue by Application (2027-2032) & (US$ Million) Table 143. China Paromomycin Sales by Application (2021-2026) & (tons) Table 144. China Paromomycin Sales by Application (2027-2032) & (tons) Table 145. China Paromomycin Sales Price by Application (2021-2026) & (US$/ton) Table 146. China Paromomycin Sales Price by Application (2027-2032) & (US$/ton) Table 147. Asia Paromomycin Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Paromomycin Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Paromomycin Sales by Type (2021-2026) & (tons) Table 150. Asia Paromomycin Sales by Type (2027-2032) & (tons) Table 151. Asia Paromomycin Sales Price by Type (2021-2026) & (US$/ton) Table 152. Asia Paromomycin Sales Price by Type (2027-2032) & (US$/ton) Table 153. Asia Paromomycin Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Paromomycin Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Paromomycin Sales by Application (2021-2026) & (tons) Table 156. Asia Paromomycin Sales by Application (2027-2032) & (tons) Table 157. Asia Paromomycin Sales Price by Application (2021-2026) & (US$/ton) Table 158. Asia Paromomycin Sales Price by Application (2027-2032) & (US$/ton) Table 159. Asia Paromomycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Paromomycin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Paromomycin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Paromomycin Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 163. Asia Paromomycin Sales by Country (2021-2026) & (tons) Table 164. Asia Paromomycin Sales by Country (2027-2032) & (tons) Table 165. Asia Paromomycin Sales Price by Country (2021-2026) & (US$/ton) Table 166. Asia Paromomycin Sales Price by Country (2027-2032) & (US$/ton) Table 167. Japan Paromomycin Revenue (2021-2032) & (US$ Million) Table 168. South Korea Paromomycin Revenue (2021-2032) & (US$ Million) Table 169. India Paromomycin Revenue (2021-2032) & (US$ Million) Table 170. Australia Paromomycin Revenue (2021-2032) & (US$ Million) Table 171. Taiwan Paromomycin Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Paromomycin Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Paromomycin Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Paromomycin Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Paromomycin Sales by Type (2021-2026) & (tons) Table 176. SAMEA Paromomycin Sales by Type (2027-2032) & (tons) Table 177. SAMEA Paromomycin Sales Price by Type (2021-2026) & (US$/ton) Table 178. SAMEA Paromomycin Sales Price by Type (2027-2032) & (US$/ton) Table 179. SAMEA Paromomycin Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Paromomycin Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Paromomycin Sales by Application (2021-2026) & (tons) Table 182. SAMEA Paromomycin Sales by Application (2027-2032) & (tons) Table 183. SAMEA Paromomycin Sales Price by Application (2021-2026) & (US$/ton) Table 184. SAMEA Paromomycin Sales Price by Application (2027-2032) & (US$/ton) Table 185. SAMEA Paromomycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Paromomycin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Paromomycin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Paromomycin Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 189. SAMEA Paromomycin Sales by Country (2021-2026) & (tons) Table 190. SAMEA Paromomycin Sales by Country (2027-2032) & (tons) Table 191. SAMEA Paromomycin Sales Price by Country (2021-2026) & (US$/ton) Table 192. SAMEA Paromomycin Sales Price by Country (2027-2032) & (US$/ton) Table 193. Brazil Paromomycin Revenue (2021-2032) & (US$ Million) Table 194. Argentina Paromomycin Revenue (2021-2032) & (US$ Million) Table 195. Chile Paromomycin Revenue (2021-2032) & (US$ Million) Table 196. Colombia Paromomycin Revenue (2021-2032) & (US$ Million) Table 197. Peru Paromomycin Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Paromomycin Revenue (2021-2032) & (US$ Million) Table 199. Israel Paromomycin Revenue (2021-2032) & (US$ Million) Table 200. UAE Paromomycin Revenue (2021-2032) & (US$ Million) Table 201. Turkey Paromomycin Revenue (2021-2032) & (US$ Million) Table 202. Iran Paromomycin Revenue (2021-2032) & (US$ Million) Table 203. Egypt Paromomycin Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Paromomycin Distributors List Table 207. Paromomycin Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Paromomycin Image Figure 2. Global Paromomycin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Paromomycin Market Size Share 2021 VS 2025 VS 2032 Figure 4. 95% Purity Type Image Figure 5. 96% Purity Type Image Figure 6. Others Image Figure 7. Global Paromomycin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Paromomycin Market Size Share 2021 VS 2025 VS 2032 Figure 9. Paromomycin Sulfate Image Figure 10. Paromomycin Injection Image Figure 11. Global Paromomycin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Paromomycin Revenue (2021-2032) & (US$ Million) Figure 13. Global Paromomycin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Paromomycin Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Paromomycin Revenue Market Share by Region (2021-2032) Figure 16. Global Paromomycin Sales (2021-2032) & (tons) Figure 17. Global Paromomycin Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 18. Global Paromomycin Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Paromomycin Sales YoY (2021-2032) & (tons) Figure 20. Europe Paromomycin Sales YoY (2021-2032) & (tons) Figure 21. China Paromomycin Sales YoY (2021-2032) & (tons) Figure 22. Asia (Excluding China) Paromomycin Sales YoY (2021-2032) & (tons) Figure 23. South America, Middle East and Africa Paromomycin Sales YoY (2021-2032) & (tons) Figure 24. Global Paromomycin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Paromomycin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Paromomycin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Paromomycin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Paromomycin Revenue Market Share by Type (2021-2032) Figure 30. Global Paromomycin Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 31. Global Paromomycin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Paromomycin Sales Market Share by Type (2021-2032) Figure 33. Global Paromomycin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Paromomycin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Paromomycin Revenue Market Share by Application (2021-2032) Figure 36. Global Paromomycin Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 37. Global Paromomycin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Paromomycin Sales Market Share by Application (2021-2032) Figure 39. North America Paromomycin Revenue Share by Type (2021-2032) Figure 40. North America Paromomycin Sales Share by Type (2021-2032) Figure 41. North America Paromomycin Revenue Share by Application (2021-2032) Figure 42. North America Paromomycin Sales Share by Application (2021-2032) Figure 43. North America Paromomycin Revenue Share by Country (2021-2032) Figure 44. North America Paromomycin Sales Share by Country (2021-2032) Figure 45. Europe Paromomycin Revenue Share by Type (2021-2032) Figure 46. Europe Paromomycin Sales Share by Type (2021-2032) Figure 47. Europe Paromomycin Revenue Share by Application (2021-2032) Figure 48. Europe Paromomycin Sales Share by Application (2021-2032) Figure 49. Europe Paromomycin Revenue Share by Country (2021-2032) Figure 50. Europe Paromomycin Sales Share by Country (2021-2032) Figure 51. China Paromomycin Revenue Share by Type (2021-2032) Figure 52. China Paromomycin Sales Share by Type (2021-2032) Figure 53. China Paromomycin Revenue Share by Application (2021-2032) Figure 54. China Paromomycin Sales Share by Application (2021-2032) Figure 55. Asia Paromomycin Revenue Share by Type (2021-2032) Figure 56. Asia Paromomycin Sales Share by Type (2021-2032) Figure 57. Asia Paromomycin Revenue Share by Application (2021-2032) Figure 58. Asia Paromomycin Sales Share by Application (2021-2032) Figure 59. Asia Paromomycin Revenue Share by Country (2021-2032) Figure 60. Asia Paromomycin Sales Share by Country (2021-2032) Figure 61. SAMEA Paromomycin Revenue Share by Type (2021-2032) Figure 62. SAMEA Paromomycin Sales Share by Type (2021-2032) Figure 63. SAMEA Paromomycin Revenue Share by Application (2021-2032) Figure 64. SAMEA Paromomycin Sales Share by Application (2021-2032) Figure 65. SAMEA Paromomycin Revenue Share by Country (2021-2032) Figure 66. SAMEA Paromomycin Sales Share by Country (2021-2032) Figure 67. Paromomycin Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Paromomycin Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 95% Purity Type
  • 96% Purity Type
  • Others
Applications
  • Paromomycin Sulfate
  • Paromomycin Injection
Companies covered
  • Shanhe Pharm
  • Kaifeng Pharm
  • Pfizer
  • Changrui Pharm
  • ERFA Canada

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Paromomycin Market by Type
  3. 1.2.1 Global Paromomycin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 95% Purity Type
  5. 1.2.3 96% Purity Type
  6. 1.2.4 Others
  7. 1.3 Paromomycin Market by Application
  8. 1.3.1 Global Paromomycin Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Paromomycin Sulfate
  10. 1.3.3 Paromomycin Injection
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Paromomycin Market Dynamics
  1. 2.1 Paromomycin Industry Trends
  2. 2.2 Paromomycin Industry Drivers
  3. 2.3 Paromomycin Industry Opportunities and Challenges
  4. 2.4 Paromomycin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Paromomycin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Paromomycin Revenue by Region
  3. 3.2.1 Global Paromomycin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Paromomycin Revenue by Region (2021-2026)
  5. 3.2.3 Global Paromomycin Revenue by Region (2027-2032)
  6. 3.2.4 Global Paromomycin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Paromomycin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Paromomycin Sales by Region
  9. 3.4.1 Global Paromomycin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Paromomycin Sales by Region (2021-2026)
  11. 3.4.3 Global Paromomycin Sales by Region (2027-2032)
  12. 3.4.4 Global Paromomycin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Paromomycin Revenue by Manufacturers
  2. 4.1.1 Global Paromomycin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Paromomycin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Paromomycin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Paromomycin Sales by Manufacturers
  6. 4.2.1 Global Paromomycin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Paromomycin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Paromomycin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Paromomycin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Paromomycin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Paromomycin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Paromomycin Manufacturers, Product Type & Application
  13. 4.7 Global Paromomycin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Paromomycin Market CR5 and HHI
  16. 4.8.2 2025 Paromomycin Tier 1, Tier 2, and Tier 3
5 Paromomycin Market by Type
  1. 5.1 Global Paromomycin Revenue by Type
  2. 5.1.1 Global Paromomycin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Paromomycin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Paromomycin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Paromomycin Sales by Type
  6. 5.2.1 Global Paromomycin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Paromomycin Sales by Type (2021-2032) & (tons)
  8. 5.2.3 Global Paromomycin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Paromomycin Price by Type
6 Paromomycin Market by Application
  1. 6.1 Global Paromomycin Revenue by Application
  2. 6.1.1 Global Paromomycin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Paromomycin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Paromomycin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Paromomycin Sales by Application
  6. 6.2.1 Global Paromomycin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Paromomycin Sales by Application (2021-2032) & (tons)
  8. 6.2.3 Global Paromomycin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Paromomycin Price by Application
7 Company Profiles
  1. 7.1 Shanhe Pharm
  2. 7.1.1 Shanhe Pharm Company Information
  3. 7.1.2 Shanhe Pharm Business Overview
  4. 7.1.3 Shanhe Pharm Paromomycin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Shanhe Pharm Paromomycin Product Portfolio
  6. 7.1.5 Shanhe Pharm Recent Developments
  7. 7.2 Kaifeng Pharm
  8. 7.2.1 Kaifeng Pharm Company Information
  9. 7.2.2 Kaifeng Pharm Business Overview
  10. 7.2.3 Kaifeng Pharm Paromomycin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Kaifeng Pharm Paromomycin Product Portfolio
  12. 7.2.5 Kaifeng Pharm Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Paromomycin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Paromomycin Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 Changrui Pharm
  20. 7.4.1 Changrui Pharm Company Information
  21. 7.4.2 Changrui Pharm Business Overview
  22. 7.4.3 Changrui Pharm Paromomycin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Changrui Pharm Paromomycin Product Portfolio
  24. 7.4.5 Changrui Pharm Recent Developments
  25. 7.5 ERFA Canada
  26. 7.5.1 ERFA Canada Company Information
  27. 7.5.2 ERFA Canada Business Overview
  28. 7.5.3 ERFA Canada Paromomycin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 ERFA Canada Paromomycin Product Portfolio
  30. 7.5.5 ERFA Canada Recent Developments
8 North America
  1. 8.1 North America Paromomycin Market Size by Type
  2. 8.1.1 North America Paromomycin Revenue by Type (2021-2032)
  3. 8.1.2 North America Paromomycin Sales by Type (2021-2032)
  4. 8.1.3 North America Paromomycin Price by Type (2021-2032)
  5. 8.2 North America Paromomycin Market Size by Application
  6. 8.2.1 North America Paromomycin Revenue by Application (2021-2032)
  7. 8.2.2 North America Paromomycin Sales by Application (2021-2032)
  8. 8.2.3 North America Paromomycin Price by Application (2021-2032)
  9. 8.3 North America Paromomycin Market Size by Country
  10. 8.3.1 North America Paromomycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Paromomycin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Paromomycin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Paromomycin Market Size by Type
  2. 9.1.1 Europe Paromomycin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Paromomycin Sales by Type (2021-2032)
  4. 9.1.3 Europe Paromomycin Price by Type (2021-2032)
  5. 9.2 Europe Paromomycin Market Size by Application
  6. 9.2.1 Europe Paromomycin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Paromomycin Sales by Application (2021-2032)
  8. 9.2.3 Europe Paromomycin Price by Application (2021-2032)
  9. 9.3 Europe Paromomycin Market Size by Country
  10. 9.3.1 Europe Paromomycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Paromomycin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Paromomycin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Paromomycin Market Size by Type
  2. 10.1.1 China Paromomycin Revenue by Type (2021-2032)
  3. 10.1.2 China Paromomycin Sales by Type (2021-2032)
  4. 10.1.3 China Paromomycin Price by Type (2021-2032)
  5. 10.2 China Paromomycin Market Size by Application
  6. 10.2.1 China Paromomycin Revenue by Application (2021-2032)
  7. 10.2.2 China Paromomycin Sales by Application (2021-2032)
  8. 10.2.3 China Paromomycin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Paromomycin Market Size by Type
  2. 11.1.1 Asia Paromomycin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Paromomycin Sales by Type (2021-2032)
  4. 11.1.3 Asia Paromomycin Price by Type (2021-2032)
  5. 11.2 Asia Paromomycin Market Size by Application
  6. 11.2.1 Asia Paromomycin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Paromomycin Sales by Application (2021-2032)
  8. 11.2.3 Asia Paromomycin Price by Application (2021-2032)
  9. 11.3 Asia Paromomycin Market Size by Country
  10. 11.3.1 Asia Paromomycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Paromomycin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Paromomycin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Paromomycin Market Size by Type
  2. 12.1.1 SAMEA Paromomycin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Paromomycin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Paromomycin Price by Type (2021-2032)
  5. 12.2 SAMEA Paromomycin Market Size by Application
  6. 12.2.1 SAMEA Paromomycin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Paromomycin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Paromomycin Price by Application (2021-2032)
  9. 12.3 SAMEA Paromomycin Market Size by Country
  10. 12.3.1 SAMEA Paromomycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Paromomycin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Paromomycin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Paromomycin Value Chain Analysis
  2. 13.1.1 Paromomycin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Paromomycin Production Mode & Process
  6. 13.2 Paromomycin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Paromomycin Distributors
  9. 13.2.3 Paromomycin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst